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Abstract
IMPORTANCE—Guidelines assert that CPM should be discouraged in patients without an 
elevated risk of a second primary breast cancer. However, little is known about the impact of 
surgeons discouraging CPM on patient care satisfaction or decisions to seek treatment from 
another clinician.
OBJECTIVE—We examined the association between patient report of first surgeon 
recommendation against CPM and the extent of discussion about it with 3 outcomes: patient 
satisfaction with surgery decisions, receipt of a second opinion, and receipt of surgery by a second 
surgeon.
DESIGN, SETTING, and PARTICIPANTS—This population-based survey study was 
conducted in Georgia and California. We identified 3880 women with stages 0 to II breast cancer 
treated in 2013–2014 through the Surveillance, Epidemiology, and End Results registries of 
Georgia and Los Angeles County. Surveys were sent approximately 2 months after surgery (71% 
response rate; n=2578). In this analysis conducted from February to May 2016, we included 
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patients with unilateral breast cancer who considered CPM (n=1,140). Patients were selected 
between July 2013 and September 2014.
PRIMARY OUTCOME AND MEASURES—We examined report of surgeon recommendations, 
level of discussion about CPM, satisfaction with surgical decision-making, receipt of second 
surgical opinion, and surgery from a second surgeon.
RESULTS—The mean (SD) age of patients in this study was 56 (10.6) years. About one-quarter 
of patients (26.7%; n=304) reported that their first surgeon recommended against CPM and 30.1% 
(n=343) reported no substantial discussion about CPM. Dissatisfaction with surgery decision was 
uncommon (7.6%; n=130), controlling for clinical and demographic characteristics. One-fifth of 
patients (20.6%; n=304) had a second opinion about surgical options and 9.8% (n=158) had 
surgery performed by a second surgeon. Dissatisfaction was very low (3.9%; n=42) among 
patients who reported that their surgeon did not recommend against CPM but discussed it. 
Dissatisfaction was substantively higher for those whose surgeon recommended against CPM with 
no substantive discussion (14.5%; n=37). Women who received a recommendation against CPM 
were not more likely to seek a second opinion (17.1% among patients with recommendation 
against CPM vs 15.1% of others, p=.52) nor to receive surgery by a second surgeon (7.9% among 
patients with recommendation against CPM vs 8.3% of others, p=.883).
CONCLUSION AND RELEVANCE—Most patients are satisfied with surgical decision making. 
First-surgeon recommendation against CPM does not appear to substantively increase patient 
dissatisfaction, use of second opinions, or loss of the patient to a second surgeon.
INTRODUCTION
Rates of contralateral prophylactic mastectomy (CPM) in the United States in women with 
unilateral breast cancer have increased dramatically, largely because of patient desires for 
the procedure.1 More patients consider CPM today because of greater awareness of the 
treatment option and psychological factors that motivate their preferences for the most 
extensive surgical treatment.2 Current clinical guidelines suggest that CPM should be 
discouraged in patients who do not have elevated risk of a second primary breast cancer 
based on family history and results of genetic testing.3,4 However, most women who 
undergo CPM after a diagnosis of breast cancer have an average risk of developing a second 
breast primary and rates of contralateral breast cancer have been decreasing steadily due to 
the increased use of adjuvant systemic therapy for early stage disease.5,6 The complex 
interaction between patient desires for the most extensive treatment and the surgeon’s role in 
minimizing surgical morbidity is poorly understood. In particular, little is known regarding 
the impact of a surgeon discouraging CPM and patient satisfaction with care or the decision 
to seek treatment with another provider. In order to address this knowledge gap we examined 
patient reactions to recommendations regarding surgery options made by their first surgical 
consultant following a diagnosis of breast cancer by considering three outcomes: patient 
satisfaction with the surgery decision, receipt of a second surgical opinion, and whether a 
second surgeon performed the definitive surgery. We also examined the extent to which 
CPM was discussed and its association with patient appraisal of surgery decision-making. 
We hypothesized that patient report of a first surgeon recommendation against CPM may 
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result in less satisfied patients, more second opinions, and greater likelihood of receipt of 
surgery from a second surgeon.
METHODS
Study Sample and Data Collection
After Institutional Review Board approval, we selected women aged 20 to 79 years and 
diagnosed with stages 0 to II breast cancer who were reported to the Surveillance 
Epidemiology and End Results (SEER) registries of Georgia and Los Angeles County. We 
received a waiver of written informed consent, as participation in the survey study (after 
receiving detailed information about the study, benefits and risks, and their rights as a 
participant) was considered adequate informed consent. Eligible patients were identified via 
initial surgical pathology reports from a list of “definitive” procedures (performed with 
intent of removing the entire tumor with clear margins). Patients were selected 
approximately 2 months after surgery and surveys were mailed on a monthly basis shortly 
after (diagnosis-survey completion average 6.0 months, sd 2.8 months). To select subjects 
with early-stage breast cancer, patients with stage III or IV disease, tumors greater than 5 
cm, or 3 or more involved lymph nodes were excluded. Black, Asian, and Hispanic women 
were oversampled in Los Angeles using an approach we previously described.7 Patients 
were selected between July 2013 and September 2014. To encourage response, we provided 
a $20 cash incentive and used a modified Dillman method for patient recruitment,8 including 
reminders to non-respondents. All materials were sent in English. We also included Spanish-
translated materials to all women with surnames suggesting Hispanic ethnicity.7 Responses 
to the survey were merged with clinical data from SEER.
We selected 3,880 women diagnosed with early-stage breast cancer in 2013–2014 based on 
rapid reporting systems from the SEER registries; among them, 249 were later deemed 
ineligible due to having a prior breast cancer diagnosis or stage III–IV disease; residing 
outside the SEER registry area; or being deceased, too ill/incompetent or unable to complete 
a survey in Spanish or English. Of 3,631 eligible women remaining, 1,053 did not return a 
survey or refused to participate. Of 2,578 patients who responded (71.0%), 110 patients with 
bilateral disease were excluded. Additionally, we excluded 1,328 patients who reported no 
consideration of CPM, leaving 1,140 (mean [SD] age, 56 [10.6] years; 46.2% of those with 
unilateral disease) for the analytic sample (Supplemental Figure 1).
Questionnaire design and content
Questionnaire content was developed based on a conceptual framework,9–12 research 
questions, and hypotheses. We developed measures drawing from the literature and our prior 
research. We utilized standard techniques to assess content validity, including systematic 
review by design experts, cognitive pretesting with patients, and pilot studies in selected 
internet and clinic populations.
Measures
There were 3 primary dependent variables in this study Dissatisfaction with the surgery 
decision was constructed from the Patient Satisfaction with the Surgery Decision Scale, 
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validated in prior studies13,14 (continuous measure range from 1.0 to 5.0 calculated by 
averaging a 5-item scale; Likert response categories 1 to 5 from not at all to very satisfied). 
This was created as a binary outcome (satisfied/dissatisfied) as this had more clinically 
meaningful interpretation. A cutoff below 3 indicated dissatisfaction. We performed 
sensitivity analyses evaluating a continuous variable and varying the cutoff for the binary 
specification. The 2 other dependent variables were whether the patient reported receiving a 
second opinion about the surgery decision (yes/no) and whether they had their breast cancer 
surgery by a second surgeon (yes/no).
There were 2 primary independent variables. Patient report of first surgeon recommendation 
about CPM was ascertained by asking patients “How strongly did the first surgeon you 
consulted recommend having a mastectomy on both breasts?” The five response categories 
were strongly/weakly recommended for CPM, left up to the patient, or strongly/weakly 
recommended against CPM. We created a binary variable a priori that indicated that the 
surgeon recommended against CPM vs recommended for CPM or it was left up to the 
patient. A level of discussion about CPM during treatment deliberation was measured using 
a 5 item assessment of whether surgeons discussed the specific benefits and risks of CPM 
with regard to: 1) survival, 2) recurrence of treated cancer, 3) occurrence of new 
contralateral cancer, 4) cosmetic outcomes, and 5) recovery from surgery. This was also 
categorized as a binary outcome for clinical interpretability. We considered that CPM was 
not substantively discussed if patients reported that it was not discussed for any of the 5 
items. Sensitivity analyses specified a priori were performed using an ordinal approach (no 
tradeoffs discussed, 3 discussed, all discussed). Additional covariates included age, marital 
status, education, insurance, race/ethnicity, and an indicator of elevated risk of second 
primary breast cancer vs average risk (based on a detailed assessment of family cancer 
history and genetic testing results) all derived from the patient survey. We also included 
geographic site and stage derived from SEER clinical information.
Analysis
First, we examined the characteristics of the total population followed by the distribution of 
key outcomes and covariates for women who reported any consideration of CPM. We then 
conducted logistic regression to examine the association between the binary variable first 
surgeon recommended against CPM and sociodemographic factors (marital status, age, 
education, race/ethnicity, paid work at time of diagnosis), risk for second primary and 
geographic site. Finally, we calculated adjusted proportions of the 3 outcome variables by 
surgeon recommendation and the CPM discussion variable by creating separate logistic 
regression models for each of the outcomes and generating the marginal probabilities, 
averaging across the independent variables. All statistical analyses incorporate weights to 
account for differential probabilities of sample selection, survey non-response and to assure 
that the distributions of our sample resemble those of the target population.15
Multiple imputations of missing data16 were used in all multivariable models to reduce 
potential for bias due to missing data, and improve efficiency by taking full advantage of our 
data. Estimates and their variances from the multiple imputation results were combined 
according to the Rubin method.17 Sensitivity analyses included re-specifying the binary 
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decision dissatisfaction variable as a continuous variable, testing different cutoffs, and 
limiting models to non-missing data.
RESULTS
Table 1 shows characteristics and outcomes for the study sample. More than half of the 
patients (56.1%) were younger than age 60 years, 25.3% completed high school or less, 
44.1% were nonwhite. More than half (57.5%) of the study sample considered CPM 
strongly or very strongly (vs weakly or moderately). Ultimately, 40.5% got breast 
conserving therapy, 22.0% unilateral mastectomy (41.4% of whom got breast 
reconstruction), and 38.2% CPM (76.7% of whom underwent breast reconstruction).
About one-quarter (26.7%) of the total study sample patients reported that their first surgeon 
recommended against CPM and 32.3% reported no substantial discussion about CPM. 
Dissatisfaction with the surgery decision was uncommon (7.6%). One-fifth of patients 
(20.6%) had a second opinion about surgical options and 9.8% had surgery performed by a 
second surgeon. Dissatisfaction with the surgery decision was higher for women who 
reported that their surgeon recommended against CPM (12.8% vs 6.5%; p<.01) or for whom 
CPM was not discussed (13.5% vs 6.0%; p<.01). Dissatisfaction was also higher among 
women who were nonwhite race, at higher risk of developing a second primary cancer, had a 
higher stage cancer, or who resided in Los Angeles County. Second opinions were more 
common among patients who were younger, more educated, did not have Medicare, and who 
worked for pay. Receipt of surgery by a second surgeon was more common among patients 
who worked for pay or who resided in Los Angeles County.
First-surgeon recommendation against CPM was highly associated with low rates of receipt 
of CPM (6.1% vs 57.5% of those with no recommendation against CPM; p<.01). Figure 1 
shows correlates of recommendations against CPM. Recommendation against CPM was 
only associated with geographic site: surgeons in Los Angeles county were more likely to 
recommend against CPM. There was no significant association with marital status, age, 
education, insurance, race/ethnicity, working for pay at time of diagnosis, or risk of 
recurrence.
Figure 2 shows the adjusted proportion of patients dissatisfied with the surgery decision by 
surgeon recommendation and extent of discussion about CPM controlling for other factors. 
Dissatisfaction was very low (3.9%) among patients who reported that their surgeon did not 
recommend against CPM but discussed it. Dissatisfaction with the surgery decision was 
somewhat higher for women whose surgeon did not recommend against CPM but did not 
substantively discuss it (7.7%; n=267) or recommended against with discussion (7.6%; 
n=244). Dissatisfaction was highest for those whose surgeon recommended against CPM 
with no substantive discussion (14.5%; n=188), but this group represented only about 13% 
of patients in the sample. Dissatisfaction differed significantly across the four groups (p<.
01).
Figure 3 shows the proportion of patients who sought a second opinion or received surgery 
by a second surgeon by first surgeon CPM recommendation categories adjusted for other 
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factors Women who received a recommendation against CPM were not more likely to seek a 
second opinion (17.1% among patients with recommendation against CPM vs 15.0% of 
others p=.52) nor to receive surgery by a second surgeon (7.9% among both patients with 
recommendation against CPM and of others, p=.88).
Hosmer-Lemeshow tests did not indicate significant lack of fit; the Chi Square statistics 
from these tests ranged from 3.4 to 9.9 across models and imputations (p= .27 – .90). 
Alternative specifications of the decision satisfaction measure looking at different cutoffs or 
treating it as a continuous variable showed no significant differences in model results. No 
significant interactions were found between any of the independent variables.
DISCUSSION
In this large diverse population-based sample of patients newly diagnosed with breast cancer 
about half with unilateral disease considered contralateral prophylactic mastectomy. Among 
these patients, about one-quarter reported that their first surgeon recommended against CPM 
and one-third reported that CPM was not substantively discussed with their surgeon(s). 
There were no significant differences in the likelihood of CPM recommendation by 
sociodemographic factors except for geographic location. Geographic variation in surgeon 
recommendation may suggest differences in practice network factors with regard to how 
surgeons approach communication about CPM. Both surgeon recommendation against CPM 
and lack of a substantive discussion were associated with patient dissatisfaction with the 
surgery decision. The additive effect was modest: nearly 15% of patients were dissatisfied 
with the surgery decision process when a first surgeon recommended against CPM but there 
was no substantive discussion about it (vs 4.0% in patients who did not receive a 
recommendation against CPM but had a discussion about it). However, only about 15% of 
patients reported this circumstance. Second opinions about surgery were not common 
(15.7%) and surgery performed by a second surgeon even less so (8.1%). First-surgeon 
recommendation against CPM was not associated with the frequency of second opinion or 
patient receipt of surgery by a second surgeon. Furthermore, there were no substantive 
sociodemographic or clinical correlates of second opinions or receipt of surgery from a 
second surgeon.
This is the first study to our knowledge that examined the nature of physician-patient 
discussions about CPM and patient reactions to surgeon recommendations regarding elective 
CPM. Published studies have documented the growth in receipt of CPM in the US over the 
last decade,6,18–21 and a few have addressed patient factors driving preferences for more 
extensive surgery.2 Other studies have examined surgeon perspectives but they have been 
limited by small samples, low response rates, or non-US practice settings.22,23
Some aspects of our study methods merit comment. The study was a large population-based 
survey in a diverse sample with a high survey response rate. We used weights and multiple 
imputation techniques to reduce non-response bias. Patient report of treatment deliberation 
and experiences were ascertained shortly after surgery. We were conservative with regard to 
specification of the main measures. For example, patients had to indicate that none of the 5 
CPM treatment tradeoffs were discussed to be characterized as not having a substantive 
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discussion. Furthermore, we performed sensitivity analyses to assure that main findings 
based on a priori decisions were robust for different specifications of key variables and 
different approaches to analyses. However, there were some limitations. Surgeon 
communication was reported by patients and thus may differ from a report from their 
surgeon. The population-based survey was necessarily retrospective. In particular, we 
evaluated strength of consideration of CPM after treatment which may have been influenced 
by deliberations and the surgical treatment ultimately performed. We had little information 
about potential barriers to discussion or care by second surgeons which may have affected 
our findings. Finally, results are limited to 2 large regions of the US.
IMPLICATIONS
Surgeons face a growing need to address patient interest in CPM for treatment of breast 
cancer. Communicating with patients about CPM is difficult because patient preferences are 
motivated by complex intuitive and affective reactions that may be difficult to elicit and 
address in a visit where a myriad of treatment options and potential outcomes need to be 
discussed. Under these circumstances, surgeons may not feel compelled to initiate a 
discussion of CPM or proactively make recommendations in women with no medical 
indication for the procedure in an effort to optimally facilitate patient participation in a 
complicated treatment decision process. Our findings are largely reassuring in that most 
patients are satisfied with surgical decision making and that first surgeon recommendation 
against CPM does not appear to substantively increase patient dissatisfaction or increase use 
of second opinions or loss of the patient to a second surgeon. However, the proportion of 
patients reporting a recommendation against CPM by their first surgeon was modest. The 
consequences of a greater number of surgeons advising against CPM are unknown, 
especially in women who strongly desire the procedure. For patients who remain uncertain 
about the benefits of CPM, a second opinion may be an appropriate source of additional 
information. Research is needed to develop and evaluate both decision tools for patients and 
training opportunities for surgeons that can facilitate these very important clinical 
encounters concerning challenging treatment decision issues.
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Figure 1. Correlates of surgeon recommendation against contralateral prophylactic mastectomy
Odds ratios (95% confidence intervals) from a logistic regression model using multiple 
imputation for missing data and weights for differing probabilities of sample selection and 
non-response. Ref indicates reference group; Dx indicates diagnosis; LA indicates Los 
Angeles County.
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Figure 2. Dissatisfaction with surgical decision by surgeon recommendation and extent of 
discussion about contralateral prophylactic mastectomy
*Predicted probabilities of surgical decision dissatisfaction. Rates are marginal predictions 
derived from a multivariable logistic model, averaging over marital status, education, 
insurance, race, employment, stage, risk of recurrence, site, and consideration for CPM.
**Weighted to account for oversampled groups in the design and non-response
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Figure 3. Receipt of second opinion or surgery by second surgeon by surgeon recommendation
* Predicted probabilities of second opinion and surgery by second surgeon. Rates are 
marginal predictions derived from a multivariable logistic model, averaging over marital 
status, education, insurance, race, employment, stage, risk of recurrence, site, and 
consideration for CPM.
**Weighted to account for oversampled groups in the design and non-response
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Table 1
Sample Characteristics
Characteristics n %
Surgeon Recommendation
  Not Against CPM 767 67.3%
  Against CPM 304 26.7%
  Missing 69 6.0%
Discussion of CPM
  Discussed 720 63.1%
  Not Discussed 343 30.1%
  Missing 77 6.8%
Age, grouped
  Less than 50 264 23.1%
  50–59 374 32.8%
  60–69 326 28.6%
  70 or Older 174 15.3%
  Missing 2 0.2%
Education
  High School or less 288 25.3%
  Some College/Technical School 360 31.6%
  College Graduate 477 41.8%
  Missing 15 1.3%
Insurance
  Private 700 61.4%
  Medicaid 152 13.3%
  Medicare 239 21.0%
  None 8 0.7%
  Missing 41 3.6%
Race/Ethnicity
  White 613 53.7%
  Black 182 16.0%
  Hispanic 210 18.4%
  Asian 92 8.1%
  Missing 43 3.8%
Marital Status
  Not Married 396 34.7%
  Married/Partner 728 63.9%
  Missing 16 1.4%
Employment Status Before Diagnosis
  Not Working For Pay 255 22.4%
  Working For Pay 748 65.6%
  Missing 137 12.0%
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Characteristics n %
Risk of Recurrence
  Not High Risk 455 39.9%
  High Risk 685 60.1%
Stage
  0 184 16.1%
  I 630 55.3%
  II 326 28.6%
Consideration of CPM
  Weak/Moderate 462 40.5%
  Strong/Very Strong 625 54.9%
  Missing 53 4.6%
Site
  Georgia 642 56.3%
  LA 498 43.7%
Ultimate Treatment
  Breast Conserving Surgery 447 39.2%
  Unilateral Mastectomy 251 22.0%
  Bilateral Mastectomy 435 38.2%
  Missing 7 0.6%
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